메뉴 건너뛰기




Volumn 142, Issue 8, 2006, Pages 976-982

Facial resurfacing for nonmelanoma skin cancer prophylaxis

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; TRICHLOROACETIC ACID;

EID: 33747626714     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.8.976     Document Type: Article
Times cited : (96)

References (34)
  • 1
    • 0023818793 scopus 로고
    • Malignant transformation of solar keratoses to squamous cell carcinoma
    • Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.
    • (1988) Lancet , vol.1 , pp. 795-797
    • Marks, R.1    Rennie, G.2    Selwood, T.S.3
  • 2
    • 0025883924 scopus 로고
    • Maligant potential of actinic keratoses and the controversy over treatment
    • Dodson JM, DeSpain J, Heweet JE, Clark DP. Maligant potential of actinic keratoses and the controversy over treatment. Arch Dermatol. 1991;127:1029-1031.
    • (1991) Arch Dermatol , vol.127 , pp. 1029-1031
    • Dodson, J.M.1    Despain, J.2    Heweet, J.E.3    Clark, D.P.4
  • 3
    • 0025779685 scopus 로고
    • The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma
    • Marks R. The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma. Arch Dermatol. 1991;127:1031-1033.
    • (1991) Arch Dermatol , vol.127 , pp. 1031-1033
    • Marks, R.1
  • 4
    • 0036144002 scopus 로고    scopus 로고
    • Patients who have multiple skin cancers develop new skin cancers at a constant rate
    • Czarnecki C, Czarnecki D. Patients who have multiple skin cancers develop new skin cancers at a constant rate [letter]. Arch Dermatol. 2002;138:125.
    • (2002) Arch Dermatol , vol.138 , pp. 125
    • Czarnecki, C.1    Czarnecki, D.2
  • 5
    • 0034536150 scopus 로고    scopus 로고
    • Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis
    • Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136:1524-1530.
    • (2000) Arch Dermatol , vol.136 , pp. 1524-1530
    • Marcil, I.1    Stern, R.S.2
  • 6
    • 0034532778 scopus 로고    scopus 로고
    • Association of basal cell skin cancers with other cancers
    • Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers. Cancer Causes Control. 2000;11:891-897.
    • (2000) Cancer Causes Control , vol.11 , pp. 891-897
    • Friedman, G.D.1    Tekawa, I.S.2
  • 8
    • 12944327339 scopus 로고    scopus 로고
    • Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma)
    • Lober BA, Fenske NA. Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol. 2004;5:395-401.
    • (2004) Am J Clin Dermatol , vol.5 , pp. 395-401
    • Lober, B.A.1    Fenske, N.A.2
  • 9
    • 0028835325 scopus 로고
    • Guidelines of care for actinic keratoses
    • Drake LA, Ceilley RI, Cornelison RL, et al; Committee on Guidelines of Care. Guidelines of care for actinic keratoses. J Am Acad Dermatol. 1995;32:95-98.
    • (1995) J Am Acad Dermatol , vol.32 , pp. 95-98
    • Drake, L.A.1    Ceilley, R.I.2    Cornelison, R.L.3
  • 10
    • 7644224775 scopus 로고    scopus 로고
    • Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze)
    • Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol. 2004;3:401-407.
    • (2004) J Drugs Dermatol , vol.3 , pp. 401-407
    • Nelson, C.1    Rigel, D.2    Smith, S.3    Swanson, N.4    Wolf, J.5
  • 11
    • 17444394323 scopus 로고    scopus 로고
    • Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials
    • Korman N, Moy R, Ling M, et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol. 2005;141:467-473.
    • (2005) Arch Dermatol , vol.141 , pp. 467-473
    • Korman, N.1    Moy, R.2    Ling, M.3
  • 12
    • 0024315946 scopus 로고
    • Laser ablation for cosmetic and medical treatment of facial actinic damage
    • David LM, Lask CP, Glassberg E, Jacoby R, Abergel RP. Laser ablation for cosmetic and medical treatment of facial actinic damage. Cutis. 1989;43:583-587.
    • (1989) Cutis , vol.43 , pp. 583-587
    • David, L.M.1    Lask, C.P.2    Glassberg, E.3    Jacoby, R.4    Abergel, R.P.5
  • 13
    • 0030667017 scopus 로고    scopus 로고
    • The carbon dioxide laser: An alternative for the treatment of actinically damaged skin
    • Trimas SJ, Ellis DA, Metz RD. The carbon dioxide laser: an alternative for the treatment of actinically damaged skin. Dermatol Surg. 1997;23:885-889.
    • (1997) Dermatol Surg , vol.23 , pp. 885-889
    • Trimas, S.J.1    Ellis, D.A.2    Metz, R.D.3
  • 14
    • 0033037208 scopus 로고    scopus 로고
    • A case report of laser resurfacing as a skin cancer prophylaxis
    • Massey RA, Eliezri YD. A case report of laser resurfacing as a skin cancer prophylaxis. Dermatol Surg. 1999;25:513-516.
    • (1999) Dermatol Surg , vol.25 , pp. 513-516
    • Massey, R.A.1    Eliezri, Y.D.2
  • 15
    • 1542343889 scopus 로고    scopus 로고
    • Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer
    • Iyer S, Friedli A, Bowes L, Kricorian G, Fitzpatrick RE. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med. 2004;34:114-119.
    • (2004) Lasers Surg Med , vol.34 , pp. 114-119
    • Iyer, S.1    Friedli, A.2    Bowes, L.3    Kricorian, G.4    Fitzpatrick, R.E.5
  • 16
    • 0030972779 scopus 로고    scopus 로고
    • Longterm efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses
    • Witheiler DD, Lawrence N, Cox SE, Cruz C, Cockerell CJ, Freemen RG. Longterm efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Dermatol Surg. 1997;23:191-196.
    • (1997) Dermatol Surg , vol.23 , pp. 191-196
    • Witheiler, D.D.1    Lawrence, N.2    Cox, S.E.3    Cruz, C.4    Cockerell, C.J.5    Freemen, R.G.6
  • 17
    • 0030913150 scopus 로고    scopus 로고
    • Manual resurfacing and trichloroacetic acid for the treatment of patients with widespread actinic damage: Clinical and histologic observations
    • Cooley JE, Casey DL, Kauffman CL. Manual resurfacing and trichloroacetic acid for the treatment of patients with widespread actinic damage: clinical and histologic observations. Dermatol Surg. 1997;23:373-379.
    • (1997) Dermatol Surg , vol.23 , pp. 373-379
    • Cooley, J.E.1    Casey, D.L.2    Kauffman, C.L.3
  • 18
    • 0028813758 scopus 로고
    • A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses
    • Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176-181.
    • (1995) Arch Dermatol , vol.131 , pp. 176-181
    • Lawrence, N.1    Cox, S.E.2    Cockerell, C.J.3    Freeman, R.G.4    Cruz Jr., P.D.5
  • 19
    • 0023722337 scopus 로고
    • Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp
    • Brodland DG, Roenigk RK. Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp. Mayo Clin Proc. 1988;63:887-896.
    • (1988) Mayo Clin Proc , vol.63 , pp. 887-896
    • Brodland, D.G.1    Roenigk, R.K.2
  • 20
    • 1242317128 scopus 로고    scopus 로고
    • Health economic evaluation of nonmelanoma skin cancer and actinic keratosis
    • Higashi MK, Veenstra DL, Langley PC. Health economic evaluation of nonmelanoma skin cancer and actinic keratosis. Pharmacoeconomics. 2004;22:83-94.
    • (2004) Pharmacoeconomics , vol.22 , pp. 83-94
    • Higashi, M.K.1    Veenstra, D.L.2    Langley, P.C.3
  • 21
    • 0026683230 scopus 로고
    • New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin: Implications and recommendations for follow-up
    • Frankel DH, Hanusa BH, Zitella JA. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin: implications and recommendations for follow-up. J Am Acad Dermatol. 1992;26:720-726.
    • (1992) J Am Acad Dermatol , vol.26 , pp. 720-726
    • Frankel, D.H.1    Hanusa, B.H.2    Zitella, J.A.3
  • 22
    • 0027392668 scopus 로고
    • Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma
    • Marghoob A, Kopf AW, Bart RS, et al. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol. 1993;28:22-28.
    • (1993) J Am Acad Dermatol , vol.28 , pp. 22-28
    • Marghoob, A.1    Kopf, A.W.2    Bart, R.S.3
  • 23
    • 11844265854 scopus 로고    scopus 로고
    • Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer
    • Chen GJ, Feldman SR, Williford PM, et al. Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg. 2005;31:43-47.
    • (2005) Dermatol Surg , vol.31 , pp. 43-47
    • Chen, G.J.1    Feldman, S.R.2    Williford, P.M.3
  • 24
    • 0037343249 scopus 로고    scopus 로고
    • Skin cancer is among the most costly of all cancers to treat for the Medicare population
    • Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48:425-429.
    • (2003) J Am Acad Dermatol , vol.48 , pp. 425-429
    • Housman, T.S.1    Feldman, S.R.2    Williford, P.M.3
  • 25
    • 0035726535 scopus 로고    scopus 로고
    • Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases
    • Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol. 2001;144:1050-1053.
    • (2001) Br J Dermatol , vol.144 , pp. 1050-1053
    • Stockfleth, E.1    Meyer, T.2    Benninghoff, B.3    Christophers, E.4
  • 26
    • 4644304377 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
    • Szeimies RM, Gerritsen MJ, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51:547-555.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 547-555
    • Szeimies, R.M.1    Gerritsen, M.J.2    Gupta, G.3
  • 27
    • 2342450044 scopus 로고    scopus 로고
    • Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials
    • Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50:714-721.
    • (2004) J Am Acad Dermatol , vol.50 , pp. 714-721
    • Lebwohl, M.1    Dinehart, S.2    Whiting, D.3
  • 28
    • 0030065403 scopus 로고    scopus 로고
    • Dermabrasion for prophylaxis and treatment of actinic keratoses
    • Coleman WP III, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg. 1996;22:17-21.
    • (1996) Dermatol Surg , vol.22 , pp. 17-21
    • Coleman III, W.P.1    Yarborough, J.M.2    Mandy, S.H.3
  • 29
    • 0032836092 scopus 로고    scopus 로고
    • Disappointing results following resufracing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers
    • Fulton JE, Rahimi AD, Helton P, et al. Disappointing results following resufracing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg. 1999;25:729-732.
    • (1999) Dermatol Surg , vol.25 , pp. 729-732
    • Fulton, J.E.1    Rahimi, A.D.2    Helton, P.3
  • 30
    • 0030962089 scopus 로고    scopus 로고
    • A peeler's thoughts on skin improvement with chemical peels and laser resurfacing
    • Rubin MG. A peeler's thoughts on skin improvement with chemical peels and laser resurfacing. Clin Plast Surg. 1997;24:407-409.
    • (1997) Clin Plast Surg , vol.24 , pp. 407-409
    • Rubin, M.G.1
  • 31
    • 33747597334 scopus 로고    scopus 로고
    • Chemical peel
    • Frederickson JM, Harker LA, Krause CJ, et al, eds. Baltimore, Md: Mosby-Year Book
    • Porter JP, Alford EL. Chemical peel. In: Frederickson JM, Harker LA, Krause CJ, et al, eds. Otolaryngology: Head and Neck Surgery. Baltimore, Md: Mosby-Year Book; 1998:640-647.
    • (1998) Otolaryngology: Head and Neck Surgery , pp. 640-647
    • Porter, J.P.1    Alford, E.L.2
  • 32
    • 3142521642 scopus 로고    scopus 로고
    • Chemical peels: Their place within the range of resurfacing techniques
    • Fulton JE, Porumb S. Chemical peels: their place within the range of resurfacing techniques. Am J Clin Dermatol. 2004;5:179-187.
    • (2004) Am J Clin Dermatol , vol.5 , pp. 179-187
    • Fulton, J.E.1    Porumb, S.2
  • 33
    • 0029859579 scopus 로고    scopus 로고
    • A clinical and histologic evaluation of two medium-depth peels: Glycolic acid versus Jessner's trichloroacetic acid
    • Tse Y, Ostad A, Lee HS, et al. A clinical and histologic evaluation of two medium-depth peels: glycolic acid versus Jessner's trichloroacetic acid. Dermatol Surg. 1996;22:781-786.
    • (1996) Dermatol Surg , vol.22 , pp. 781-786
    • Tse, Y.1    Ostad, A.2    Lee, H.S.3
  • 34
    • 0030005199 scopus 로고    scopus 로고
    • Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin
    • Humphreys TR, Werth V, Dzubow L, Kligman A. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin. J Am Acad Dermatol. 1996;34:638-644.
    • (1996) J Am Acad Dermatol , vol.34 , pp. 638-644
    • Humphreys, T.R.1    Werth, V.2    Dzubow, L.3    Kligman, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.